Guangzhou LBP Medicine Science & Technology Co Ltd (688393) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.024x

Based on the latest financial reports, Guangzhou LBP Medicine Science & Technology Co Ltd (688393) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥29.17 Million ≈ $4.27 Million USD) by net assets (CN¥1.20 Billion ≈ $175.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Guangzhou LBP Medicine Science & Technol (688393) net asset quality to measure how much of total assets are equity-financed.

Guangzhou LBP Medicine Science & Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Guangzhou LBP Medicine Science & Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Guangzhou LBP Medicine Science & Technol's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Guangzhou LBP Medicine Science & Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou LBP Medicine Science & Technology Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Aviva PLC LSE:AV	0.039x
Nanning Baling Technology SHE:002592	-0.008x
M3-Brigade Acquisition V Corp. Units NASDAQ:MBAVU	-0.004x
H+H International A/S CO:HH	0.054x
Krakatau Steel Persero Tbk JK:KRAS	-0.195x
Cosmo Chem KO:005420	0.086x
Imperial Brands PLC LSE:IMB	-0.086x
Zhonglu Co Ltd A SHG:600818	-0.026x

Annual Cash Flow Conversion Efficiency for Guangzhou LBP Medicine Science & Technology Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Guangzhou LBP Medicine Science & Technology Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Guangzhou LBP Medicine Science & Technol market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.23 Billion ≈ $180.24 Million	CN¥3.54 Million ≈ $518.49K	0.003x	-79.19%
2023-12-31	CN¥1.24 Billion ≈ $181.20 Million	CN¥17.12 Million ≈ $2.51 Million	0.014x	+73.94%
2022-12-31	CN¥1.22 Billion ≈ $178.87 Million	CN¥9.72 Million ≈ $1.42 Million	0.008x	-83.87%
2021-12-31	CN¥1.21 Billion ≈ $177.02 Million	CN¥59.61 Million ≈ $8.72 Million	0.049x	-37.07%
2020-12-31	CN¥1.17 Billion ≈ $170.85 Million	CN¥91.43 Million ≈ $13.38 Million	0.078x	-61.20%
2019-12-31	CN¥444.63 Million ≈ $65.06 Million	CN¥89.74 Million ≈ $13.13 Million	0.202x	+20.24%
2018-12-31	CN¥389.32 Million ≈ $56.97 Million	CN¥65.35 Million ≈ $9.56 Million	0.168x	-30.73%
2017-12-31	CN¥346.28 Million ≈ $50.67 Million	CN¥83.92 Million ≈ $12.28 Million	0.242x	+79.32%
2016-12-31	CN¥320.94 Million ≈ $46.96 Million	CN¥43.37 Million ≈ $6.35 Million	0.135x	+4270.59%
2013-12-31	CN¥215.00 Million ≈ $31.46 Million	CN¥-696.70K ≈ $-101.95K	-0.003x	-111.61%
2012-12-31	CN¥173.32 Million ≈ $25.36 Million	CN¥4.84 Million ≈ $707.67K	0.028x	+108.80%
2011-12-31	CN¥48.09 Million ≈ $7.04 Million	CN¥-15.24 Million ≈ $-2.23 Million	-0.317x	--

About Guangzhou LBP Medicine Science & Technology Co Ltd

SHG:688393 China Medical Instruments & Supplies

Market Cap

$258.50 Million

CN¥1.77 Billion CNY

Market Cap Rank

#15527 Global

#4562 in China

Share Price

CN¥18.88

Change (1 day)

+0.37%

52-Week Range

CN¥16.21 - CN¥34.80

All Time High

CN¥58.43